Valuation: Southern Acids (M)

Market Cap 412M 102M 90.99M 83.72M 75.86M 142M 9.65B 145M 997M 399M 5.07B 382M 373M 16.02B P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value -14.29M -3.53M -3.16M -2.9M -2.63M -4.92M -335M -5.02M -34.59M -13.85M -176M -13.23M -12.95M -555M EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.2%
Yield 2025
1.64%
Yield 2026 1.65%
Oct. 19 Southern Acids (M) Berhad Reports Group Production Results for the Month of September 2026 CI
Oct. 01 Southern Acids (M) Berhad Reassigns Lee Weng Hoong as Principal Officer, Effective October 1, 2026 CI
Sep. 08 Southern Acids (M) Berhad Reports Group Production Results for the Month of August 2026 CI
Aug. 28 Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
Aug. 28 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
Aug. 28 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Non Independent and Non Executive Director, Effective August 28, 2026 CI
Aug. 28 Southern Acids (M) Berhad Announces Appointment of Dato' Sri Dr Low Kok Thye as Acting Chairman, Effective August 28, 2026 CI
Aug. 26 Southern Acids (M) Berhad Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
Aug. 13 Southern Acids (M) Berhad Reports Group Production Results for the Month of July 2026 CI
Aug. 05 Southern Acids (M) Berhad Announces Redesignation of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie from Independent Director to Non-Independent Director, Effective August 5, 2026 CI
Jul. 27 Southern Acids (M) Berhad Announces Single Tier Final Dividend on Ordinary Share for Financial Year Ending March 31, 2027, Payable on 11 November 2026 CI
Jul. 14 Southern Acids (M) Berhad Reports Group Production Results for the Month of June 2026 CI
Jun. 16 Southern Acids (M) Berhad Reports Group Production Results for the Month of May 2026 CI
1 day-2.27%
1 week-2.27%
Current month-2.90%
1 month-2.90%
3 months-0.33%
6 months-5.94%
Current year-5.35%
1 week 3.01
Extreme 3.01
3.01
1 month 3.01
Extreme 3.01
3.18
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.5
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 46 2015-07-14
Chief Tech/Sci/R&D Officer 38 2014-07-15
Corporate Secretary - 2023-03-26
Director TitleAgeSince
Director/Board Member 66 2005-08-09
Director/Board Member 59 2012-03-19
Chairman 46 2026-08-27
Change 5-day change 1-year change 3-year change Capi.($)
-2.27%-2.27%-7.38%-7.10% 102M
-0.39%+1.80%+14.56%+51.40% 48.5B
-1.82%-3.63%-19.84%+11.76% 34.73B
-0.82%-1.94%-14.28%-15.57% 15.78B
+2.49%+13.12%-17.65%+8.17% 11.36B
0.00%-1.50%-7.08%+6.49% 4.77B
-1.66%-4.41%-33.44%-36.92% 4.44B
-3.47%+5.99%-19.15%+276.09% 4.35B
-1.44%-5.52%-6.16%-4.53% 3.84B
-1.34%-3.92%-9.33%+4.67% 3.57B
Average -1.07%-0.49%-11.97%+29.45% 13.14B
Weighted average by Cap. -0.76%+0.51%-5.57%+29.03%

Financials

2025 2026
Net sales 1.11B 273M 244M 225M 204M 380M 25.9B 388M 2.68B 1.07B 13.6B 1.02B 1B 42.97B 934M 230M 206M 190M 172M 321M 21.86B 328M 2.26B 904M 11.48B 864M 846M 36.27B
Net income 36.7M 9.05M 8.1M 7.46M 6.75M 12.62M 860M 12.88M 88.82M 35.55M 451M 33.97M 33.25M 1.43B 37.38M 9.22M 8.25M 7.59M 6.88M 12.85M 875M 13.12M 90.46M 36.2M 460M 34.6M 33.86M 1.45B
Net Debt -367M -90.5M -80.99M -74.52M -67.52M -126M -8.59B -129M -888M -355M -4.51B -340M -332M -14.26B -426M -105M -94.14M -86.63M -78.49M -147M -9.99B -150M -1.03B -413M -5.25B -395M -386M -16.57B
Projected Income Statement - Annual - Southern Acids (M)
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
26-10-26 MYR 3.010 -2.27% 1,000
26-10-23 MYR 3.080 0.00% 5,000
  1. Stock Market
  2. Stocks
  3. 5134 Stock